Cantley LC - Search Results

1

The phosphoinositide 3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through negative regulation of growth factor signaling.

Taniguchi CM, Winnay J, Kondo T, Bronson RT, Guimaraes AR, Alemán JO, Luo J, Stephanopoulos G, Weissleder R, Cantley LC, Kahn CR. Taniguchi CM, et al. Among authors: cantley lc. Cancer Res. 2010 Jul 1;70(13):5305-15. doi: 10.1158/0008-5472.CAN-09-3399. Epub 2010 Jun 8. Cancer Res. 2010. PMID: 20530665 Free PMC article.

2

Novel polyphosphoinositides in cell growth and activation.

Auger KR, Cantley LC. Auger KR, et al. Among authors: cantley lc. Cancer Cells. 1991 Jul;3(7):263-70. Cancer Cells. 1991. PMID: 1654970 Review.

3

The lipid products of phosphoinositide 3-kinase increase cell motility through protein kinase C.

Derman MP, Toker A, Hartwig JH, Spokes K, Falck JR, Chen CS, Cantley LC, Cantley LG. Derman MP, et al. Among authors: cantley lc, cantley lg. J Biol Chem. 1997 Mar 7;272(10):6465-70. doi: 10.1074/jbc.272.10.6465. J Biol Chem. 1997. PMID: 9045671 Free article.

4

Phosphoinositide 3-kinase regulates phospholipase Cgamma-mediated calcium signaling.

Rameh LE, Rhee SG, Spokes K, Kazlauskas A, Cantley LC, Cantley LG. Rameh LE, et al. Among authors: cantley lc, cantley lg. J Biol Chem. 1998 Sep 11;273(37):23750-7. doi: 10.1074/jbc.273.37.23750. J Biol Chem. 1998. PMID: 9726983 Free article.

5

The role of phosphoinositide 3-kinase lipid products in cell function.

Rameh LE, Cantley LC. Rameh LE, et al. Among authors: cantley lc. J Biol Chem. 1999 Mar 26;274(13):8347-50. doi: 10.1074/jbc.274.13.8347. J Biol Chem. 1999. PMID: 10085060 Free article. Review. No abstract available.

6

New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.

Cantley LC, Neel BG. Cantley LC, et al. Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4240-5. doi: 10.1073/pnas.96.8.4240. Proc Natl Acad Sci U S A. 1999. PMID: 10200246 Free PMC article. Review.

7

SYK is upstream of phosphoinositide 3-kinase in B cell receptor signaling.

Beitz LO, Fruman DA, Kurosaki T, Cantley LC, Scharenberg AM. Beitz LO, et al. Among authors: cantley lc. J Biol Chem. 1999 Nov 12;274(46):32662-6. doi: 10.1074/jbc.274.46.32662. J Biol Chem. 1999. PMID: 10551821 Free article.

8

Impaired kit- but not FcepsilonRI-initiated mast cell activation in the absence of phosphoinositide 3-kinase p85alpha gene products.

Lu-Kuo JM, Fruman DA, Joyal DM, Cantley LC, Katz HR. Lu-Kuo JM, et al. Among authors: cantley lc. J Biol Chem. 2000 Feb 25;275(8):6022-9. doi: 10.1074/jbc.275.8.6022. J Biol Chem. 2000. PMID: 10681597 Free article.

9

Phosphoinositide 3-kinase knockout mice: role of p85alpha in B cell development and proliferation.

Fruman DA, Snapper SB, Yballe CM, Alt FW, Cantley LC. Fruman DA, et al. Among authors: cantley lc. Biochem Soc Trans. 1999 Aug;27(4):624-9. doi: 10.1042/bst0270624. Biochem Soc Trans. 1999. PMID: 10917654 Review. No abstract available.

10

Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha.

Fruman DA, Mauvais-Jarvis F, Pollard DA, Yballe CM, Brazil D, Bronson RT, Kahn CR, Cantley LC. Fruman DA, et al. Among authors: cantley lc. Nat Genet. 2000 Nov;26(3):379-82. doi: 10.1038/81715. Nat Genet. 2000. PMID: 11062485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

666 results

Search Page